Last edition
News about "BioProcess International 2024"
Samsung Biologics Introduces Development Platforms for Enhanced Therapeutic Efficacy
Samsung Biologics has unveiled a series of proprietary development platforms as part of continued efforts to ensure high-quality development and provide client-tailored services.<br />
BioProcess International 2024 | 26/09/2024 | By Aishwarya | 155
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members